Register Login
Register to leave comments
  • News bot Sept. 4, 2025, 11:55 p.m.

    🔍 BELANOFF JOSEPH K (Executive)

    Company: CORCEPT THERAPEUTICS INC (CORT)

    Report Date: 2025-09-02

    Transaction Summary:

    • Total transactions: 2
    • Derivative instruments: 0
    • Holdings reported: 0
    • Total shares sold: 40,000

    Detailed Transactions and Holdings:

    • Sold 39,300 shares of Common Stock at $70.5172 per share (Direct)
      Date: 2025-09-02 | Code: S | equity_swap_involved: false | shares_owned_after: 2,822,070.00 | transaction_form_type: 4 | Footnotes: F1, F2, F3
    • Sold 700 shares of Common Stock at $71.0107 per share (Direct)
      Date: 2025-09-02 | Code: S | equity_swap_involved: false | shares_owned_after: 2,821,370.00 | transaction_form_type: 4 | Footnotes: F1, F4, F3

    Footnotes:

    • F1: This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 26, 2024 in effect at the time of this transaction.
    • F2: Represents the weighted average sale price for the entire number of shares sold. The actual sale prices range from $69.97 to $70.96 per share. Information on the exact number of shares sold at each sale price can be obtained from the Issuer upon request.
    • F3: Reporting Person has voting power over the shares held by the Joseph K. Belanoff and Katherine A. Blenko Revocable Living Trust DTD 04/29/02 pursuant to voting agreements and disclaims beneficial ownership of all of such shares, except to the extent of his pecuniary interest therein.
    • F4: Represents the weighted average sale price for the entire number of shares sold. The actual sale prices range from $70.97 to $71.085 per share. Information on the exact number of shares sold at each sale price can be obtained from the Issuer upon request.
    • REMARKS: The power of attorney under which this form was signed is on file with the Commission.

Search

News categories